Borgeson Blake
SEC Form 4 insider trading activity
Borgeson Blake has filed 11 SEC Form 4 filings (11 transaction rows) across 1 company, with disclosures dating back to 2025. 11 of those filings fall inside the rolling window. Most recent filing: Sep 2, 2026.
On the most recent filing, Borgeson Blake is listed as Director at RECURSION PHARMACEUTICALS, INC. Inside the rolling window, Borgeson Blake reported no open-market purchases and 10 open-market sales totaling $4.1M in RXRX. The largest disclosed transaction in the window is a sale of 220,000 RXRX shares on Dec 2, 2025, worth $961K.
Companies traded
Other insiders at RXRX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$4.1M
reported sales (SEC code S)
Companies
1
in the rolling window
| Source | |||||||
|---|---|---|---|---|---|---|---|
| RXRX | Director | Sale | 30,000 | $100K | Sep 2 | SEC ↗ | |
| RXRX | Director | Sale | 30,000 | $98K | Aug 6 | SEC ↗ | |
| RXRX | Director | Sale | 40,000 | $159K | Jul 9 | SEC ↗ | |
| RXRX | Director | Sale | 30,000 | $110K | Jun 4 | SEC ↗ | |
| RXRX | Director | Sale | 30,000 | $106K | May 7 | SEC ↗ | |
| RXRX | Director | Sale | 30,000 | $93K | Apr 8 | SEC ↗ | |
| RXRX | Director | Sale | 170,000 | $588K | Mar 4 | SEC ↗ | |
| RXRX | Director | Sale | 220,000 | $924K | Feb 6 | SEC ↗ | |
| RXRX | Director | Sale | 220,000 | $959K | Jan 8 | SEC ↗ | |
| RXRX | Director | Sale | 220,000 | $961K | Dec 4 | SEC ↗ |
Frequently asked questions
How many SEC Form 4 filings has Borgeson Blake made?
Borgeson Blake has filed 11 SEC Form 4 filings (11 transaction rows) across 1 company since 2025.
Which companies does Borgeson Blake trade?
Borgeson Blake has filed SEC Form 4 disclosures for 1 company, including RXRX.
When was Borgeson Blake's most recent SEC Form 4 filing?
Borgeson Blake's most recent SEC Form 4 filing on Tracefour is dated Sep 2, 2026.
What is Borgeson Blake's total buy and sell value in the current window?
Inside the rolling retention window, Borgeson Blake bought $0 and sold $4.1M based on SEC Form 4 filings.
What was Borgeson Blake's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 220,000 RXRX shares on 2025-12-02, worth $961K, per SEC Form 4 filings.